Discontinuation Of Sale Of Ceftobiprole In Canada
April 13, 2010 – 1:21 amBasilea Pharmaceutica Ltd. (SIX: BSLN) announces that Janssen-Ortho Inc., a Johnson & Johnson company, has in consultation with Health Canada decided to discontinue sale of ceftobiprole (ZEFTERA™) for the treatment of complicated skin and skin structure infections (cSSSI) in Canada. Janssen-Ortho Inc., the holder of the Market Authorization in Canada, is discontinuing sale of ZEFTERA™ effective April 16, 2010. This action is being taken by Janssen-Ortho Inc…
Find more info about Discontinuation Of Sale Of Ceftobiprole In Canada photos videos pictures. read more
Related Info :
Tags: April 16, Basilea Pharmaceutica, Bsln, Canada, Canada Photos, Canada Pictures, Ceftobiprole, Consultation, Discontinuation, Health Canada, Janssen Ortho Inc, Johnson Johnson, Johnson Johnson Company, Photos Pictures, Sale, Skin And Skin, Skin Structure Infections, Videos
Sorry, comments for this entry are closed at this time.